GEORGE VAN BUREN to Pancreatic Neoplasms
This is a "connection" page, showing publications GEORGE VAN BUREN has written about Pancreatic Neoplasms.
Connection Strength
2.526
-
Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection. Nutrients. 2017 Mar 07; 9(3).
Score: 0.340
-
Phase II study of induction fixed-dose rate gemcitabine and bevacizumab followed by 30 Gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarcinoma. Ann Surg Oncol. 2013 Nov; 20(12):3787-93.
Score: 0.265
-
Tumor Immune Microenvironment Differences Associated With Racial Disparities in Pancreatic Cancer. J Surg Res. 2025 Mar; 307:21-32.
Score: 0.147
-
Interobserver Variability and Challenges in Intraoperative Frozen Section Evaluation of Pancreatic Margins in Pancreatectomy Specimens. Ann Clin Lab Sci. 2023 Nov; 53(6):847-860.
Score: 0.135
-
CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer. Cancer Res. 2023 04 04; 83(7):1111-1127.
Score: 0.129
-
Factors associated with inability to return to intended oncologic treatment in pancreatic cancer. Am J Surg. 2022 07; 224(1 Pt B):635-640.
Score: 0.120
-
Clinical Translation and Evaluation of a Handheld and Biocompatible Mass Spectrometry Probe for Surgical Use. Clin Chem. 2021 09 01; 67(9):1271-1280.
Score: 0.116
-
Rapid diagnosis and tumor margin assessment during pancreatic cancer surgery with the MasSpec Pen technology. Proc Natl Acad Sci U S A. 2021 07 13; 118(28).
Score: 0.115
-
Long-Term Assessment of Pancreatic Function After Pancreatectomy for Cystic Neoplasms. J Surg Res. 2020 03; 247:547-555.
Score: 0.102
-
Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing. Am J Gastroenterol. 2019 09; 114(9):1539-1549.
Score: 0.101
-
Mutant p53R175H promotes cancer initiation in the pancreas by stabilizing HSP70. Cancer Lett. 2019 07 01; 453:122-130.
Score: 0.098
-
Mesothelin and TGF-a predict pancreatic cancer cell sensitivity to EGFR inhibitors and effective combination treatment with trametinib. PLoS One. 2019; 14(3):e0213294.
Score: 0.098
-
SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma. Cancer Lett. 2019 02 01; 442:310-319.
Score: 0.095
-
Understaging of clinical stage I pancreatic cancer and the impact of multimodality therapy. Surgery. 2019 02; 165(2):307-314.
Score: 0.095
-
Venous thrombosis following pancreaticoduodenectomy with venous resection. J Surg Res. 2018 08; 228:271-280.
Score: 0.092
-
Value of lymph node positivity in treatment planning for early stage pancreatic cancer. Surgery. 2017 09; 162(3):557-567.
Score: 0.087
-
Overexpression of Semaphorin-3E enhances pancreatic cancer cell growth and associates with poor patient survival. Oncotarget. 2016 Dec 27; 7(52):87431-87448.
Score: 0.084
-
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation. Cell Rep. 2016 Feb 02; 14(4):907-919.
Score: 0.079
-
Pancreatic cancer disparities in African Americans. Pancreas. 2015 May; 44(4):522-7.
Score: 0.075
-
Pancreatic cancer: advances in treatment. World J Gastroenterol. 2014 Jul 28; 20(28):9354-60.
Score: 0.071
-
Neuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma. Clin Cancer Res. 2008 Dec 15; 14(24):8052-60.
Score: 0.048
-
Standard Operating Procedures for Biospecimen Collection, Processing, and Storage: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. Pancreas. 2018 Nov/Dec; 47(10):1213-1221.
Score: 0.024
-
Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells. Cancer Metastasis Rev. 2007 Dec; 26(3-4):433-41.
Score: 0.011